Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata may protect against graft dysfunction, while asthma may increase its risk.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Melanocytes are important for normal body functions and have potential uses in regenerative medicine and disease treatment.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Early treatment of Folliculitis Decalvans in children can improve inflammation and partially regrow hair.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Low oxygen conditions improve how well certain stem cells from embryos can make hair grow longer and faster.

Some children may develop hair loss after having COVID-19.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

Certain genes are linked to type 1 and type 2 diabetes in kids, and changes in these genes can also cause other diabetes-related conditions.

Advancements in tissue engineering show promise for hair follicle regeneration to treat hair loss.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Careful management of steroid use is crucial in pregnant women with bullous pemphigoid to avoid complications like Cushing syndrome.

Chitosan-based hydrogels effectively control bleeding and have promising medical uses.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

Cell extracts may effectively and safely repair radiation-damaged salivary glands.

The HATMSC1 cell line from fat tissue can produce helpful factors for regenerative and immune therapies.

Injectable hydrogels are becoming increasingly useful in medicine for drug delivery and tissue repair.

Skin maturation in Dezhou donkey foals involves better barrier function, hair growth, and less collagen production.

A new treatment using microneedles with black phosphorus and laser helps regrow hair effectively and safely.

Electrospun 3D nanofibrous materials show promise for bone regeneration in orthopaedics.

Platelet-rich plasma helps treat hair loss, and better screening improves transfusion safety.

Major histocompatibility antigens are found in specific skin cells and structures, but not in sweat glands.

Natural killer cells play a key role in autoimmune skin diseases like pemphigus vulgaris.